Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
- 9 February 2011
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 117 (1), 100-111
- https://doi.org/10.1111/j.1471-4159.2011.07178.x
Abstract
The blockade of adenosine A(2A) receptors (A2AR) affords a robust neuroprotection in different noxious brain conditions. However, the mechanisms underlying this general neuroprotection are unknown. One possible mechanism could be the control of neuroinflammation that is associated with brain damage, especially because A2AR efficiently control peripheral inflammation. Thus, we tested if the intracerebroventricular injection of a selective A2AR antagonist (SCH58261) would attenuate the changes in the hippocampus triggered by intraperitoneal administration of lipopolysaccharide (LPS) that induces neuroinflammation through microglia activation. LPS administration triggers an increase in inflammatory mediators like interleukin-1β that causes biochemical changes (p38 and c-jun N-terminal kinase phosphorylation and caspase 3 activation) contributing to neuronal dysfunction typified by decreased long-term potentiation, a form of synaptic plasticity. Long-term potentiation, measured 30 min after the tetanus, was significantly lower in LPS-treated rats compared with control-treated rats, while SCH58261 attenuated the LPS-induced change. The LPS-induced increases in phosphorylation of c-jun N-terminal kinase and p38 and activation of caspase 3 were also prevented by SCH58261. Significantly, SCH58261 also prevented the LPS-induced recruitment of activated microglial cells and the increase in interleukin-1β concentration in the hippocampus, indicating that A2AR activation is a pivotal step in mediating the neuroinflammation triggered by LPS. These results indicate that A2AR antagonists prevent neuroinflammation and support the hypothesis that this mechanism might contribute for the ability of A2AR antagonists to control different neurodegenerative diseases known to involve neuroinflammation.Keywords
This publication has 53 references indexed in Scilit:
- Caffeine attenuates lipopolysaccharide-induced neuroinflammationNeuroscience Letters, 2010
- Adenosine A2A receptor mediates microglial process retractionNature Neuroscience, 2009
- Key Modulatory Role of Presynaptic Adenosine A2AReceptors in Cortical Neurotransmission to the Striatal Direct PathwayThe Scientific World Journal, 2009
- Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber SynapsesNeuron, 2008
- Population Control of Resident and Immigrant Microglia by Mitosis and ApoptosisThe American Journal of Pathology, 2007
- Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neuronsNeurobiology of Disease, 2007
- Interleukin-1 and neuronal injuryNature Reviews Immunology, 2005
- Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockadePurinergic Signalling, 2005
- Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout miceBritish Journal of Pharmacology, 2004
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976